Skip to main content

Journal Club - May 27, 2021


Dr. Michael Thibert presented the RATE-AF Trial, which is a prospective, randomized, open-label, blinded, endpoint trial comparing the use of digoxin and beta-blockers as initial rate control therapy for permanent atrial fibrillation. This trail was published in JAMA this past December.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC